Scrip
No reprieve on deceptive intent, as US High Court declines to hear Lovenox
01 May 2009
Nancy Faigen
The US Supreme Court has declined to hear an appeal by
Sanofi-Aventis on its long-running dispute relating to a US patent challenge by Amphastar Pharmaceuticals. The justices let stand rulings that Sanofi's main patent for low-molecular weight heparin Lovenox (enoxaparin sodium) is unenforceable because...
Please Login to read the full article.
01 May 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Merck & Co challenge to Vioxx securities lawsuit gets US high court hearing next week
- US high court lets stand attorneys' fee award to Takeda in Actos patent case
- US supreme court to hear Merck & Co's appeal of Vioxx securities fraud case
- US court rejects pharma views against new patent rules
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
